Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic
1,884.90 INR-0.79%As of 2026-11-22 · INR
Last session low 1,883.00 INRLast session high 1,910.00 INR
52-week low 1,583.70 INR52-week high 2,046.90 INR
Market cap (USD)
$48.80B
Sector
Healthcare
P/E (TTM)
41.2x
Dividend yield
0.85%
Next earnings
2027-01-28 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in INR.

IndicatorValueReading
RSI (14)61.6In the neutral range (30 to 70)
MACD (12, 26, 9)25.09Above its signal line (17.76); histogram 7.33
Bollinger %B (20, 2)72%Inside the bands (1,701.20 to 1,954.64)
SMA 201,827.92Price is 3.1% above
SMA 501,818.74Price is 3.6% above
SMA 2001,819.06Price is 3.6% above
ATR (20)2.03% of priceAverage true range per day
52-week position65%In the middle of the 1,583.70 to 2,046.90 range

About Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

Latest fiscal yearEnded 2026-03-31: revenue of 582.20B INR and an operating margin of 23.4%.
Next earnings reportExpected on 2027-01-28 (the date is an estimate).

More in Drug Manufacturers - Specialty & Generic